Anderson M, Svartengren M, Dahlback M, Nerbrink O, Philipson K and Camner P. Human tracheobronchial deposition and effect of two cholinergic aerosols. Experimental Lung Research. 19(6):653-69, 1993.

Berg E, Bäckström K, Dahlbäck M and Nerbrink O. Output and Particle size distribution of pulmicort suspension generated from MAD2 and PariBoy nebulizers. J. Aerosol Sci. Vol 19 (7) 1988. (Abstract)

Dennis JH, Pieron CA, Pagels J, Smurthwaite M, Nerbrink O. Development and application of a low flow cascade impactor to size nebulized aerosols. J. Aerosols Med, 12 (2), 134, 1999.

Dennis JH, Pieron CA and Nerbrink O.Standards in assessing in vitro nebulizer performance. Eur Repir Rev, 10, 72, pp178-192, 2000.

Dennis JH, Knoch M, Nerbrink O, Denyer J, Boe J. Summary of the ERS Nebulizer Guidelines Technical Workshop and Introduction to the CEN in vitro methods of assessing nebulizer performance. Eur Respir Rev 2000;10:497-502.

Dahlbäck, M, Nerbrink, O, Arborelius, M, Hansson, H C. Output characteristics from three medical nebulizers. J. Aer. Sci. 17 (1986) 563-564.

Dahlbäck, M, Eirefelt, S, Karlberg, I.-B Nerbrink, O. Total deposition of Evans blue in aerosol exposed rats and guinea pigs. J. Aerosol Sci. 20: 1325-1327, 1989.

Dahlbäck M, Eirefelt S, Nerbrink O, Prytz M, G-Wagner Z. A new aerosol delivery system to dogs. J Aerosol Sci., Vol 21, Suppl. 1 pp 467-470, 1990.

Eirefelt S, Nerbrink O, Dahlbäck M. Selective aerosol delivery to intubated rats; a comparison with nose only exposure. J Aerosol Sci. Vol23, Suppl 1, 491-494, 1992. (Abstract)

J.H. Dennis and O. Nerbrink. Atomization and nebulizers. Lung Biol- ogy in Health and Disease: Inhalation Aerosols (Edited by Hickey, A.), 94:273-312, 1996.

J.H. Dennis and O. Nerbrink. New nebulizer technology. Lung Biology in Health and Disease: Drug Delivery to the Lung (Edited by Bisgaard, H.), 162:303{336, 2002.

Mitchell J P, Nagel M W, Nichols S, Nerbrink, O ; Laser Diffractometry as a Technique for the Rapid Assessment of Aerosol Particle Size from Inhalers; J Aeroisol Med 19:4, 2006

Nerbrink O. Dahlbäck M. and Hansson C-H. The Nebulizer function; Primary and secondary generation. J Aerosol Sci. Vol 23. Suppl 1. 217-220, 1992. (Abstract)

Nerbrink O, Dahlback M, Hansson HC. Why do medical nebulizers differ in their output and particle characteristics? J Aerosol Med 1994:7:259-276.

Nerbrink O and Dahlback M. Basic nebulizer function. Journal of Aerosol Medicine. 7(Suppl 1):S7-11, 1994.

Nerbrink O and Ekelius C. Investigation of the pulse from two different commercial dosimeters. J Aerosol Med 1997;10: 272 [abstract].

Nerbrink O L, Lindstrom M, Meurling L and Svartengren M. Inhalation and deposition of nebulized sodium cromoglycate in two different particle size distributions in children with asthma. Pediatr Pulmonol. 34: 351-360,2002.

Nerbrink O L, Pagels J, Pieron C A, and Dennis J H. Effect of Humidity on Constant Output and Breath Enhanced Nebulizer Designs When Tested in the EN 13544-1 EC Standard. Aerosol Sci Technol. 37 (3): 282-292, 2003.

Nerbrink O, Fagerström P-O, Wendel T, Eirefelt S, Källén A, Marchner H and Dahlbäck M. A Novel Dry Powder Aerosol Delivery System for Real Time Measurement of the Inhaled Dose to Large Animals (Dogs). Aerosol Sci and Technol. Vol 27 (2) pp 147-161, 1997.

Nerbrink O, Dennis J H, Pagels J and Pieron C A. Technical aspects of nebulizers used in dosimetry Europ Respir Rev. (10)72. pp 232-237, 2000.

Svartengren K, Philipson K, Svartengren M, Nerbrink O and Camner P. Clearance in smaller airways of inhaled 6-XXm particles in subjects with Immotile-cilia syndrome. Exp Lung Res 21:667-682, 1995.

Svartengren M, Skogward P, Nerbrink O and Dahlbäck M. Regional deposition of inhaled evans blue dye in mechanically ventilated rabbits with air or helium oxygen mixture. Exp Lung Res 24:159-172, 1998.